跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 321 条关于
“TLX250-Tx”
全部
321
临床试验
163
药物
54
机构
40
资讯
64
2个月前
Telix Opens Australia's First Integrated Radiopharmaceutical Facility to Accelerate Cancer Theranostics
前天
FDA Approves Telix's Pixclara, First FET-PET Imaging Drug for Glioma in the U.S.
7年前
FDA Issues Complete Response Letter for Telix's Kidney Cancer Imaging Agent TLX250-CDx
去年
Novamigra Tx Advances Migraine Therapy with FDA's Endorsement for Accelerated Clinical Development
11个月前
TLX250-CDx Shows Promise in Triple Negative Breast Cancer as OPALESCENCE Trial Results Published
去年
Telix Pharmaceuticals' TLX250-CDx Enters Phase II Trial for Recurrent Kidney Cancer Detection
去年
Telix Pharmaceuticals' TLX250-CDx Phase III Trial for Kidney Cancer Imaging Doses First Patient in China
4个月前
TLX250-Px Shows Promise for Diagnosing Multiple Kidney Cancer Types Beyond Clear Cell Renal Cell Carcinoma
2年前
TLX250-CDx Shows High Accuracy in Kidney Cancer Imaging: Phase 3 ZIRCON Trial Published
10个月前
Castle Biosciences Launches AdvanceAD-Tx Gene Expression Test to Guide Atopic Dermatitis Treatment Selection
第 1 页,共 7 页
上一页
下一页